Press Releases | Medtronic

Month Year

Email alerts

Nov 8, 2011

Study of Medtronic Endeavor(R) Drug-Eluting Stent Demonstrates Long-Term Advantages over Taxus(R) DES

Final Five-Year Follow-up of Randomized ENDEAVOR IV Trial Shows Durable Safety and Efficacy of Endeavor DES, with Comparatively Lower Rates of Cardiac Death/Myocardial Infarction and Very Late Stent Thrombosis

SAN FRANCISCO, Nov 08, 2011 (BUSINESS WIRE) -- New research findings released at TCT 2011 show that the Endeavor(R) zotarolimus-eluting stent (DES) from Medtronic, Inc. (NYSE: MDT) outperformed...
Nov 7, 2011

Medtronic CoreValve(R) System Gains CE Mark for New Direct Aortic Approach to Transcatheter Aortic Valve Implantation

New Access Will Expand Treatment Options for Patients with Severe Aortic Stenosis

MINNEAPOLIS, Nov 07, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced it has received CE (Conformité Européenne) Mark for the Medtronic CoreValve(R) System to be delivered...
Nov 4, 2011

Medtronic's Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

Presentations Cover Stents and Balloons for Coronary and Peripheral Artery Disease, Transcatheter Valve for Aortic Stenosis, Stent Grafts for Aortic Aneurysms, and Renal Denervation for Treatment-Resistant Hypertension and Heart Failure

MINNEAPOLIS, Nov 04, 2011 (BUSINESS WIRE) -- Offering the broadest range of medical technology for the interventional and surgical treatment of cardiovascular disease, Medtronic, Inc. (NYSE: MDT)...
Nov 3, 2011

Medtronic Announces Global Launch of the T2 ALTITUDE(TM) Expandable Corpectomy Device

The latest advancement in expandable cage technology for surgeons, hospitals and patients

MEMPHIS, Tenn., Nov 03, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) announced the global launch of the T2 ALTITUDE(TM) Expandable Corpectomy Device in the U.S. and Europe today at the North...
Nov 2, 2011

Medtronic Begins Transcatheter Aortic Valve Trial in Japan

MINNEAPOLIS, Nov 02, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the first implant in a clinical trial in Japan that will evaluate the safety and effectiveness of the...
Nov 2, 2011

Medtronic Introduces New Procedure for Minimally Invasive Spinal Fusion

MEMPHIS, Tenn., Nov 02, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) the world leader in spinal technology, announced today a pioneering approach to minimally invasive spinal fusion at the 26th
Nov 2, 2011

Medtronic Announces Launch of Mini EVS 3.4 Epidural Vein Sealer at 26th Annual Meeting of North American Spine Society

MINNEAPOLIS, Nov 02, 2011 (BUSINESS WIRE) -- To address surgeon needs of rapidly managing hemostasis in minimally invasive spine surgery, Medtronic, Inc. (NYSE: MDT) announced today the launch of...
Oct 31, 2011

Medtronic Receives First FDA Approval of Cobalt Chromium Balloon-Expandable Stent to Treat Narrowed Iliac Arteries

Assurant(R) Cobalt Iliac Stent Features Novel Alloy and Modular Design; Augments Company's Peripheral Portfolio with Balloon-Expandable Option

MINNEAPOLIS, Oct 31, 2011 (BUSINESS WIRE) -- Advancing the treatment of peripheral artery disease, Medtronic, Inc. (NYSE: MDT) today announced approval by the U.S. Food and Drug Administration...
Oct 28, 2011

Medtronic Named One of the "World's 25 Best Multinational Workplaces"

MINNEAPOLIS, Oct 28, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today The Great Place to Work Institute(R) included the company on the inaugural "World's 25 Best Multinational...
Oct 28, 2011

Medtronic Receives IDE Approval to Conduct ASPIRE In-Home Study of First Insulin Pump with Low Glucose Suspend for US Market

A Critical Step Toward the Development of an Artificial Pancreas, Low Glucose Suspend Aims to Reduce Hypoglycemia

MINNEAPOLIS, Oct 28, 2011 (BUSINESS WIRE) -- In our continued commitment to develop an artificial pancreas, Medtronic, Inc. (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA)...

Show per page